GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » EV-to-FCF

Colinz Laboratories (BOM:531210) EV-to-FCF : (As of Apr. 17, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Colinz Laboratories's Enterprise Value is ₹61.21 Mil. Colinz Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.00 Mil. Therefore, Colinz Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Colinz Laboratories's EV-to-FCF or its related term are showing as below:

BOM:531210' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 4.72
Current: 4.72

During the past 13 years, the highest EV-to-FCF of Colinz Laboratories was 4.72. The lowest was 0.00. And the median was 0.00.

BOM:531210's EV-to-FCF is ranked better than
91.94% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.125 vs BOM:531210: 4.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-17), Colinz Laboratories's stock price is ₹53.00. Colinz Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹1.910. Therefore, Colinz Laboratories's PE Ratio (TTM) for today is 27.75.


Colinz Laboratories EV-to-FCF Historical Data

The historical data trend for Colinz Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories EV-to-FCF Chart

Colinz Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.47 -0.11 14.07 8.34 2.93

Colinz Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.93 - - -

Competitive Comparison of Colinz Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Colinz Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's EV-to-FCF falls into.


;
;

Colinz Laboratories EV-to-FCF Calculation

Colinz Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=61.213/0
=

Colinz Laboratories's current Enterprise Value is ₹61.21 Mil.
Colinz Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Colinz Laboratories  (BOM:531210) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Colinz Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=53.00/1.910
=27.75

Colinz Laboratories's share price for today is ₹53.00.
Colinz Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.910.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Colinz Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Colinz Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India based company engaged in trading and manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories Headlines

No Headlines